A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 375-380

  Chaowagul, Wipada ^a,b,c,d   Simpson, Andrew J H ^a,b,c,d   Suputtamongkol, Yupin ^a,b,c,d,e   Smith, Michael D ^a,b,c,d,f   Angus, Brian J ^a,b,c,d   White, Nicholas J ^a,b,c,d  

^a Sappasitthiprasong Hospital   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Centre for Tropical Medicine   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e MAHIDOL UNIVERSITY   (Thailand)

^f MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME;

EID: 0032769578     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520218     Document Type: Article

References (11)

1. 1. Chaowagul W. Melioidosis: a treatment challenge. Scand J Infect Dis Suppl 1996;101:14-6.
2. 2. Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DAB, White NJ. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg 1995;89:546-9.
3. 3. Chaowagul W, Suputtamongkul Y, Smith MD, White NJ. Oral fluoroquinolones for maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg 1997;91:599-601.
4. 4. Dance DAB, Wuthiekanun V, Chaowagul W, White NJ. Interactions in vitro between agents used to treat melioidosis. J Antimicrob Chemother 1989;24:311-6.
5. 5. Dance DAB, Wuthiekanun V, Chaowagul W, White NJ. The antimicrobial susceptibility of Pseudomonas pseudomallei: emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989;24:295-309.
6. 6. Currie B, Howard D, Nguyen VT, Withnall K, Merianos A. The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: clinical aspects. Southeast Asian J Trop Med Public Health 1993;24: 436-43.
7. 7. Walsh AL, Wuthiekanun V. The laboratory diagnosis of melioidosis. Br J Biomed Sci 1996;53:249-53.
8. 8. Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 1991;27(suppl D):1-50.
9. 9. Chaowagul W, Suputtamongkol Y, Dance DAB, Rajchanuvong A, Pattara-Arechachai J, White NJ. Relapse in melioidosis: incidence and risk factors. J Infect Dis 1993;168:1181-5.
10. 10. White NJ, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989;2:697-701.
11. 11. Suputtamongkol Y, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, White NJ. Amoxycillin clavulanic acid treatment of melioidosis. Trans R Soc Trop Med Hyg 1991;85:672-5.